Pharmaceutical Technology

OCTOBER 18, 2022

These investments are anchored by LSP 7 with institutional investors, including Earlybird, Novartis Venture Fund, funds managed by Tekla Capital Management, Pivotal bioVenture Partners and VI Partners among others also taking part. The deal is also expected to offer proceeds comprising nearly $127.5m

59

59

Pharmaceutical Technology

MAY 12, 2023

Early-stage life sciences investment fund NYBC Ventures has launched its new $50m fund to speed up developments in the fields of blood and cellular therapies and related technologies. The New York Blood Center (NYBC) has provided the investment for the inaugural fund.

52

52

pharmaphorum

JANUARY 6, 2022

Morgan week has historically brought large flocks of investors, industry and companies raising funding rounds to San Francisco every January. What are likely to be the key topics at J.P. A huge topic in the USA today is health equity – this will also be reflected in most of the discussions. Why are you attending the virtual J.P.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Hospitals 115

Pharma Marketing Network

OCTOBER 27, 2021

Some topics discussed include: Patient Advocacy Groups. Funding for these groups. Trust issues associated with funding. Alison Bateman-House, Research Assistant Professor of Medical Ethics at NYU School of Medicine, during an episode on the DarshanTalks podcast. Listen Here.

40

40

Pharmaceutical Technology

AUGUST 22, 2022

Porton Advanced Solutions has raised $80m in a Series B funding round to expand its end-to-end gene and cell therapy (GCT) contract development and manufacturing organisation (CDMO) platforms. Additionally, various venture and private equity firms, including Gortune Investment, SDICTK and Fosun Health Capital, took part in the funding round.

52

52

Pharmaceutical Technology

MARCH 17, 2023

This collaboration is intended to fund up to three research grants that are focused on antibody-drug conjugates (ADCs) for improving the outcomes for lung cancer patients. Topic sponsors are not involved in the creation of editorial content. Early R&D projects coverage on Pharmaceutical Technology is supported by Mimotopes.

98

98

Pharmaceutical Technology

MAY 31, 2023

The funding will also be used to work on Anocca’s cell therapy discovery and manufacturing process. The round was led by the Swedish pension fund AMF and the investment firm Mellby Gård. This equity funding round adds to the €25 million ($26.62 Topic sponsors are not involved in the creation of editorial content.

Vaccines 52

Vaccines 52

pharmaphorum

OCTOBER 18, 2022

Topical therapies like OCS-01 would complement current approaches by adding an option with improved patient comfort, safety, accessibility, cost, and allowing individualised dosing. Leading institutional investors include Earlybird and Novartis Venture Fund, with funds managed by Tekla Capital Management LLC and VI Partners, among others.

59

59

Pharmaceutical Technology

APRIL 27, 2023

New investors included the Redmile Group, the Abu Dhabi Growth Fund (ADG), Exor, Invus, Moore Strategic Ventures, the iGlobe Platinum Fund Group and Casdin Capital. Orbital will use the new funding to increase the application of RNA-based medicines for use in the fields of new vaccines, immunomodulation and protein replacement.

Vaccines 52

Vaccines 52

Hospital Pharmacy Europe

MAY 22, 2023

Reporting the results in the BMJ , researchers from the University of Southampton said the NIHR-funded trial was the first to provide clinical evidence that spironolactone was effective for the skin condition. Differences were seen by 12 weeks but were more marked and statistically significant by 24 weeks, they said.

Hospitals 102

Hospitals 102

Pharmaceutical Technology

OCTOBER 11, 2022

LifeLink, LifeForce Capital, Selvridge, Backed VC, Khosla Ventures, Hermes-Epitek, AixThera, EIT, along with individual investors, Verge Genomics CEO Alice Zhang, BioAge CEO Kristen Fortney, and Recursion Pharmaceuticals chairman Marty Chavez have participated in the funding round.

52

52

European Pharmaceutical Review

OCTOBER 13, 2022

Inflammatory conditions such as ulcerative colitis have could be treated with topical medications using this innovative approach by maximising local concentration of the drug in the tissue. The research was partly funded by the National Institutes of Health (NIH) and MIT’s Department of Mechanical Engineering.

136

136

Roots Analysis

APRIL 5, 2023

Billions of Dollars are Being Invested in Funding the Initiatives of Various Players Engaged in the Antiviral Drugs Domain Maximum number of funding instances (49) were reported in the year 2020, followed by 44 instances, recorded in the year 2021.

52

52

Pharmaceutical Technology

MAY 10, 2023

The government had called for Gilead to “respect the US patent system” and the taxpayer-funded research undertaken by the CDC, per the statement. This research dates to the mid-2000s when CDC scientists developed the PrEP regimen, argued the government. The November 2019 lawsuit marked a further escalation in an existing dispute.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies FDA 105

NICE

DECEMBER 14, 2022

Our ultimate aim is to update recommendations on key topics within 3 to 6 months of new, practice-changing evidence emerging. funding by Wellcome to produce guidance on regulating digital mental health tools, a key area of need. Together with the Medicines and Healthcare products Regulatory Agency, NICE was awarded £1.8m

97

97

Pharmaceutical Technology

MAY 18, 2023

Funding for the deal includes $20m from the existing investment of Forbion Growth in FEAC Class A shares, along with PIPE investment, other private investment and a non-redemption commitment of almost $115m. Topic sponsors are not involved in the creation of editorial content.

52

52

PharmaShots

MARCH 30, 2023

Equity investment into Galimedix supports Galimedix's pipeline development TOI gets an exclusive right to develop & commercialize Galimedix’s GAL-101 for topical & oral treatment of dry AMD, glaucoma & other ophthalmic indications in the EU, the Americas, the Middle East & Africa.

40

40

PQA

FEBRUARY 9, 2023

This year will feature a few familiar PQA events, each with its own focus and objectives, as well as some topic-based events focused on key areas that impact medication use. Be sure to join our Quality Forum Webinar mailing list to receive updates on monthly webinar topics.

52

52

pharmaphorum

AUGUST 16, 2021

UK psychedelic medicine specialist Beckley Psytech has raised an impressive £58 million (around $80 million) in an oversubscribed second-round financing that will help fund clinical development of its psilocybin-based therapies.

Compounding 135

Compounding 135

Pharmaceutical Technology

JUNE 7, 2023

The latest funding brings the total venture capital financing secured by the company so far to $259m. Topic sponsors are not involved in the creation of editorial content. The financing round, led by Digital Mobile Venture, has also seen participation from other existing investors.

59

59

Pharmaceutical Technology

OCTOBER 13, 2022

Vita Therapeutics intends to use the funding to advance its lead pre-clinical programme VTA-100 for limb-girdle muscular dystrophy (LGMD2A) to clinical trials. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

52

52

Pharmaceutical Technology

AUGUST 1, 2022

The US Department of Health and Human Services, and Administration for Strategic Preparedness and Response (ASPR) and others are supporting the deal through federal funds. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Vaccines 115

Vaccines FDA 115

Roots Analysis

AUGUST 16, 2023

TIL-based Therapies – Funding and Investments Several investors, having realized the opportunity within this upcoming segment of T-cell immunotherapy , have invested USD 2.7 In addition, majority (37%) of the companies primarily received funding through secondary offering. billion, across 30 instances, since 2013.

52

52

Pharmaceutical Technology

MAY 30, 2023

The company will receive substantial funding to advance AAV-ColQ gene therapy. Topic sponsors are not involved in the creation of editorial content. AMP-201 addresses the severe congenital myasthenic syndrome (CMS) caused by collagen Q (ColQ) deficiency.

97

97

Pharmaceutical Technology

MAY 19, 2023

Myeloid Therapeutics will use the funds to expedite the development of its first-in-class trophoblast cell-surface antigen 2 (TROP2)-FcA mRNA-LNP product, MT-302, into a Phase I/II trial for treating TROP2-expressing tumours. Topic sponsors are not involved in the creation of editorial content.

Labelling 98

Labelling 98

Roots Analysis

AUGUST 7, 2023

More than USD 8,250 Million was Raised by Players Engaged in Cell Free Expression Industry The field has seen a significant rise in the number of funding instances over the past few years. In addition, maximum funding was raised through IPOs followed by funding raised through venture rounds.

52

52

Pharmaceutical Technology

MARCH 30, 2023

The topical and oral form of the compound is intended to treat glaucoma and dry age-related macular degeneration (AMD), as well as other ophthalmic indications with high unmet medical need, in Africa, the Middle East, the Americas and Europe.

Compounding 52

Compounding 52

pharmaphorum

AUGUST 17, 2021

Daphne explains how she built an impressive team of board advisors for her company, plus the challenges and experience of fund raising. They also delve into PureTech’s pioneering ‘hub and spoke’ business model and how it is becoming increasingly popular.

Communication 110

Communication Immunization 110

NICE

FEBRUARY 14, 2022

NIHR have been screening NICE guidance for nearly 20 years to identify topics suitable for commissioning research. NIHR has launched a new researcher-led rolling funding call, which will complement existing commissioning workstreams. For more information on how to apply for the new rolling funding call, visit the NIHR funding webpage.

52

52

Pharmaceutical Technology

NOVEMBER 30, 2022

The University of Texas Medical Branch (UTMB) and HDT Bio have received a funding worth up to $87.4m Additionally, the funds are intended to advance the vaccines to successful conclusion of Phase I clinical trials. Topic sponsors are not involved in the creation of editorial content. Free Whitepaper.

Vaccines 59

Vaccines Communication 59

Pharmaceutical Technology

MARCH 29, 2023

The companies will co-fund research and development for all products and split the future commercial expenses and profits equally. Topic sponsors are not involved in the creation of editorial content. Sonoma will also be eligible to receive a development milestone payment of $45m.

98

98

PharmaShots

JANUARY 23, 2023

Until recently, there were very few topical options available for treating plaque psoriasis long-term. Typically, some patients start with topical steroids; however, these can be challenging, as many are limited by where they can be applied on the body and for how long and how often they can be used. [i] of VTAMA cream?

FDA 40

FDA Labelling Immunization 40

Pharmaceutical Technology

JUNE 13, 2023

The funding, with participation from Oxford Science Enterprises (OSE), includes AGTC’s acquisition and capital to help accelerate Beacon Therapeutics’ candidate development. Topic sponsors are not involved in the creation of editorial content. The total financing was £96m ($120m).

98

98

pharmaphorum

JUNE 15, 2022

An elite faculty of speakers will present on crucial topics such as rigorous clinical trial data exchange, and guide discussion through vital non-clinical focus points such as IP and funding strategy – as well as cutting edge insights from the academic world.

52

52

Roots Analysis

AUGUST 30, 2023

The Rise of Tissue Engineering Grants The availability of grant funding is critical to the advancement of tissue engineering-based regeneration products. Grants provide the necessary funding to support these activities, allowing researchers to explore new avenues of research and advance the field.

52

52

DiversifyRx

MAY 7, 2024

PBMs require that the coupon is funded by the manufacturer, not a wholesaler or a pharmacy. Coupons from these companies are funded by wholesalers and pharmacies. This confusion is common for many topicals or oral solutions. This question is a great place to start. What primary insurance does the patient have?

Independent Pharmacies 52

Independent Pharmacies Insurance FDA 52

European Pharmaceutical Review

AUGUST 3, 2022

The ideas and proposals put forward on this topic during the recent EDQM Symposium on Nanomedicines will be taken into account during the process, as will the experience gained with these vaccines during the COVID-19 pandemic, in which mRNA vaccines garnered regulatory approval for the first time.

Vaccines 92

Vaccines 92